Kennedy Barbara Bormann - Oct 5, 2021 Form 3 Insider Report for Xeris Biopharma Holdings, Inc. (XERS)

Role
Director
Signature
/s/ Beth Hecht as Attorney-in-Fact
Stock symbol
XERS
Transactions as of
Oct 5, 2021
Transactions value $
$0
Form type
3
Date filed
10/5/2021, 05:20 PM
Previous filing
Jun 8, 2021
Next filing
Jun 9, 2022

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney